CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net loss	$ (2,089,263)	$ (2,147,268)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	689,712	771,904
Depreciation-Right of Use Assets	24,259	80,117
Stock based compensation	671,158	394,870
Fair value adjustment of warrants	12,483	0
Gain on marketable securities	(17,702)	0
Amortization of financing fees	2,500	1,250
Recovery of doubtful accounts	(81,753)	(18,000)
Derecognition of contingency and grant	(10,000)	(110,000)
Third party rights agreement termination	0	(420,000)
Change in operating assets and liabilities:
Accounts receivable	(702,421)	496,349
Prepaid expenses, unbilled revenue and other current assets	(849,218)	(136,586)
Referral and support services agreement advance	75,000	0
Accrued expenses and other liabilities	(977,599)	(97,455)
Accounts payable	(327,918)	(1,257,828)
Net cash used in operating activities	(3,580,762)	(2,442,647)
Investing activities:
Purchases of equipment and capitalized development costs	(466,634)	(411,400)
Purchase of marketable securities	(1,081,080)	0
Proceeds from the sale of marketable securities	548,589	0
Net cash used in investing activities	(999,125)	(411,400)
Financing activities:
Proceeds from sale of common stock, net	0	13,137,500
Proceeds from ValidClick licensing agreement	0	(149,900)
Payments on finance lease obligations	(24,407)	(59,219)
Proceeds from exercise of options	0	1,569
Net taxes paid on restricted stock unit grants exercised	(128,521)	(161,244)
Net cash (used in)/provided by financing activities	(152,928)	12,768,706
Net change – cash	(4,732,815)	9,914,659
Cash and cash equivalent, beginning of year	10,475,964	7,890,665
Cash and cash equivalent, end of period	5,743,149	17,805,324
Supplemental information:
Interest paid	$ 7,782	21,656
Non cash investing and financing activities:
Assets purchased under operating lease obligations		$ 303,031